Drug Profile


Alternative Names: Cholestran

Latest Information Update: 28 Jan 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Alpha-Beta Technology [CEASED]
  • Class Antihyperlipidaemics
  • Mechanism of Action Bile acid binding protein modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypercholesterolaemia

Most Recent Events

  • 28 Jan 1999 Discontinued-Preclinical for Hypercholesterolaemia in USA (Unknown route)
  • 20 Aug 1997 No-Development-Reported for Hypercholesterolaemia in USA (Unknown route)
  • 01 Feb 1995 Preclinical development for Hypercholesterolaemia in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top